Effect of insulin on plasma postheparin lipoprotein lipase activity in patients with coronary sclerosis and in control subjects.
D001161:Arteriosclerosis / Q000201:enzymology; D003327:Coronary Disease / Q000201:enzymology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology*; D008071:Lipoprotein Lipase / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D006493:Heparin; D008071:Lipoprotein Lipase